-
November 2012 Litigation And Settlements Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits
Bayer Has Settled Less Than Half The DVT And PE Blood Clot Claims Filed Or Cases Subject To Tolling Agreements (Posted by Tom Lamb at DrugInjuryWatch.com) In late October 2012 we received the Bayer Stockholders’ Newsletter…
-
The Drug-Induced Pancreatitis Safety Problem That Hangs Around Victoza Gets Another Look
The Relatively New Diabetes Medication Victoza From Novo Nordisk Was Only Approved By FDA In 2010 (Posted by Tom Lamb at DrugInjuryWatch.com) In November 2012 The Annals of Pharmacotherapy published online before print this new…
-
Pradaxa Safety Debate Continues During November 2012 With Many Different Conclusions And Positions
While Doctors And Hospitals Handle Patients Having Serious Bleeding Events From Pradaxa, The Drug Company Along With The FDA Still Say All Is Fine, Here (Posted by Tom Lamb at DrugInjuryWatch.com) There was a flurry of activity in the…
-
Fresenius GranuFlo Product Has Been Associated With Heart Problems And Cardiopulmonary Arrest During Dialysis Treatment
Fresenius Failed To Warn About Risks Of Sudden Heart Attack, Stroke, And Death Caused By GranuFlo Increasing The Level Of Bicarbonate In Blood (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: Federal court GranuFlo…
-
NuvaRing: Plaintiffs’ Expert Reports Made Available By New Jersey Judge Based On Public’s Right Of Access To Judicial Proceedings
Defendants Had Sought To Keep Sealed Some Documents That Show NuvaRing Estrogen Levels Were Apparently Concealed Or Misrepresented By Organon (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: A similar Order was issued on…